Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solutions for tissue repair, ultimately aiming to enhance patients' health and overall quality of life. The company's primary product in development is GelrinC, a novel, cell-free, ready-to-use hydrogel designed to be solidified into an implant within the knee. This implant serves to address painful knee injuries and mend articular cartilage damage. Regentis Biomaterials leverages its proprietary Gelrin platform, which employs biodegradable hydrogel implants, to develop orthopedic therapies that facilitate the regeneration of compromised or diseased tissues. The company was established in 2004 and operates from its headquarters in Herzliya, Israel.

อุตสาหกรรม

Medical - Instruments & Supplies

ภาคส่วน

Healthcare

สำนักงานใหญ่

IL

ซีอีโอ

Ehud Geller

จดทะเบียนตั้งแต่

4 ธ.ค. 2568

พนักงาน

10